Providence Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,700
| Closed | -$783K | – | 240 |
|
|
2024
Q3 | $783K | Sell |
8,700
-61,317
| -88% | -$5.52M | 0.16% | 87 |
|
|
2024
Q2 | $5.51M | Buy |
70,017
+70,000
| +411,765% | +$5.51M | 1.2% | 37 |
|
|
2024
Q1 | $1.48K | Sell |
17
-62,083
| -100% | -$5.41M | ﹤0.01% | 307 |
|
|
2023
Q4 | $5.12M | Buy |
62,100
+6,600
| +12% | +$544K | 1.23% | 36 |
|
|
2023
Q3 | $4.35M | Buy |
+55,500
| New | +$4.35M | 1.14% | 42 |
|
|
2023
Q2 | – | Sell |
-56,100
| Closed | -$4.52M | – | 318 |
|
|
2023
Q1 | $4.52M | Buy |
56,100
+8,500
| +18% | +$685K | 1.2% | 40 |
|
|
2022
Q4 | $3.73M | Sell |
47,600
-200
| -0.4% | -$15.7K | 1.01% | 47 |
|
|
2022
Q3 | $3.89M | Buy |
47,800
+4,400
| +10% | +$358K | 1.17% | 35 |
|
|
2022
Q2 | $3.92M | Buy |
43,400
+3,200
| +8% | +$289K | 1.14% | 29 |
|
|
2022
Q1 | $4.46M | Buy |
40,200
+40,175
| +160,700% | +$4.46M | 1.09% | 32 |
|
|
2021
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 298 |
|
|
2021
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 271 |
|
|
2021
Q2 | $3K | Sell |
25
-82
| -77% | -$9.84K | ﹤0.01% | 276 |
|
|
2021
Q1 | $13K | Hold |
107
| – | – | ﹤0.01% | 192 |
|
|
2020
Q4 | $13K | Buy |
107
+82
| +328% | +$9.96K | 0.01% | 204 |
|
|
2020
Q3 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 189 |
|
|
2020
Q2 | – | Sell |
-100
| Closed | -$9K | – | 232 |
|
|
2020
Q1 | $9K | Buy |
+100
| New | +$9K | 0.01% | 175 |
|
|
2019
Q3 | – | Sell |
-30,600
| Closed | -$2.98M | – | 241 |
|
|
2019
Q2 | $2.98M | Buy |
30,600
+30,525
| +40,700% | +$2.97M | 1.77% | 9 |
|
|
2019
Q1 | $7K | Buy |
+75
| New | +$7K | ﹤0.01% | 198 |
|
|
2018
Q2 | – | Sell |
-24,100
| Closed | -$1.93M | – | 254 |
|
|
2018
Q1 | $1.93M | Buy |
24,100
+958
| +4% | +$76.8K | 1.45% | 20 |
|
|
2017
Q4 | $1.87M | Buy |
+23,142
| New | +$1.87M | 1.44% | 23 |
|